RecruitingPhase 4NCT06144125

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Prothrombin Complex Concentrate and Fresh Frozen Plasma in Viscoelastic Test-based Goal-directed Bleeding Management in Cardiac Surgery

Sponsor

Konkuk University Medical Center

Enrollment

100 participants

Start Date

Mar 27, 2026

Study Type

INTERVENTIONAL

Conditions

Cardiac Valve Disease

Summary

The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.

Eligibility

Min Age: 20 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called fresh frozen plasma and a biological treatment called prothrombin complex concentrate for people with cardiac valve disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.